Health
American Oncology Network and The Center for Cancer and Blood Disorders Welcome Dr. Garrett Diltz and Dr. Shreya Desai
Board-certified medical oncologists join AON’s CCBD physician teamBETHESDA, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), are pleased to welcome Board-certified medical oncologists Garrett Diltz, MD, and Shreya Desai, MD, to the care team. Both physicians will serve patients in Bethesda and Germantown, Maryland,
About this update from Aon Plc
[{"type":"image","alt":"American Oncology Network","displaySize":"","headline":null,"caption":"American Oncology Network","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":109,"url":"https://media.zenfs.com/en/globenewswire.com/4951e556d9ba9a3b499222e1d75dc487"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/xYGUeeQaq6O8UVUpyYHeyg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE1MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/4951e556d9ba9a3b499222e1d75dc487","width":300,"height":109}},"lazy":false},{"type":"text","content":"Board-certified medical oncologists join AON’s CCBD physician team","length":66,"tagName":"p"},{"type":"text","content":"BETHESDA, Md., Aug. 07, 2025 (GLOBE NEWSWIRE) -- American Oncology Network (AON), one of the nation’s fastest-growing networks of community-based oncology practices, and its partner practice, The Center for Cancer and Blood Disorders (CCBD), are pleased to welcome Board-certified medical oncologists Garrett Diltz, MD, and Shreya Desai, MD, to the care team. Both physicians will serve patients in Bethesda and Germantown, Maryland, alongside the practice’s existing team of experienced providers.","length":498,"tagName":"p"},{"type":"image","alt":"13282_CCBD_Desai-Diltz_Press-Release_Headshot_250801 (4)","displaySize":"","headline":null,"caption":"13282_CCBD_Desai-Diltz_Press-Release_Headshot_250801 (4)","className":"","disableSlideshowImg":false,"size":{"original":{"width":521,"height":365,"url":"https://media.zenfs.com/en/globenewswire.com/983f05c7b1110e0fdd0c0f1e47444a48"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/87q8n3sgJAW.DFSZd8mh3g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY3MztjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/983f05c7b1110e0fdd0c0f1e47444a48","width":521,"height":365}}},{"type":"text","content":"","length":0,"tagName":"p"},{"type":"text","content":"Dr. Diltz earned his medical degree from The Ohio State University College of Medicine, graduating summa cum laude and as a member of the Alpha Omega Alpha Honor Society. He completed his residency at Beth Israel Deaconess Medical Center/Harvard Medical School and his hematology-oncology fellowship at MedStar Georgetown University Hospital, where he was chief fellow.","length":369,"tagName":"p"},{"type":"text","content":"“My goal is to provide personalized cancer care that supports the whole patient,” s...